Updating results

Bair Hugger for measuring core temperature during perioperative care (MIB99)

Advice on the use of the Bair Hugger system for measuring core temperature during perioperative care to aid local decision-making

Medtech innovation briefing Published March 2017

Zio Service for detecting cardiac arrhythmias (MIB101)

Advice on the use of the Zio Service (a remote cardiac monitoring system) for detecting cardiac arrhythmias to aid local decision-making

Medtech innovation briefing Published March 2017

Mollii suit for spasticity (MIB100)

Advice on the use of Mollii suit (formerly Elektrodress; a therapeutic electrical stimulation jacket and trousers) for spasticity to aid local decision-making

Medtech innovation briefing Published March 2017

Mitochondrial disorders in children: Co-enzyme Q10 (ES11)

Summary of the evidence on co-enzyme Q10 for mitochondrial disorders in children to inform local NHS planning and decision-making

Evidence summary Published March 2017

Patient group directions

Everything NICE has said on systems and processes to develop, authorise, use, and update patient group directions in an interactive flowchart

NICE Pathway Published December 2014 Last updated March 2017

Gallstone disease

Everything NICE has said on diagnosing and managing gallstone disease in adults in an interactive flowchart

NICE Pathway Published October 2014 Last updated March 2017

Hyperhidrosis: oxybutynin (ES10)

Summary of the evidence on oxybutynin for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Evidence summary Published March 2017

Parkinson's disease with end-of-dose motor fluctuations: opicapone (ES9)

Summary of the evidence on opicapone for reducing end-of-dose motor fluctuations in Parkinson’s disease to inform local NHS planning and decision-making

Evidence summary Published March 2017

Narcolepsy with or without cataplexy in adults: pitolisant (ES8)

Summary on the evidence on pitolisant for treating narcolepsy with or without cataplexy to inform local NHS planning and decision-making

Evidence summary Published March 2017

SimpliCT laser-guided needle placement in interventional radiology (MIB98)

Advice on the use of SimpliCT laser-guided needle placement in interventional radiology (using CT or cone-beam CT imaging) to aid local decision-making

Medtech innovation briefing Published March 2017

TopClosure Tension Relief System for wound closure (MIB97)

Advice on the use of the TopClosure Tension Relief System for wound closure to aid local decision-making

Medtech innovation briefing Published March 2017

Skin involvement in systemic sclerosis: rituximab (ES7)

Summary of the evidence on rituximab (MabThera) for treating skin involvement in systemic sclerosis to inform local NHS planning and decision-making

Evidence summary Published March 2017

Parkinson's disease with motor fluctuations: safinamide (ES6)

Summary of the evidence on safinamide for treating Parkinson’s disease with motor fluctuations to inform local NHS planning and decision-making

Evidence summary Published February 2017

Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide (ES5)

Summary of the evidence on oral glycopyrronium bromide for severe sialorrhoea (drooling) in children and young people with chronic neurological disorders

Evidence summary Published February 2017

Smart One for measuring lung function (MIB96)

Advice on the use of Smart One for measuring lung function to aid local decision-making

Medtech innovation briefing Published February 2017

U-Drain for people needing night drainage of urine or dialysis fluid (MIB95)

Advice on the use of the U-Drain drainage system for people needing night drainage of urine or dialysis fluid to aid local decision-making

Medtech innovation briefing Published February 2017

eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)

Advice on the use of eazyplex SuperBug kits for detecting carbapenemase-producing organisms (bacteria) to aid local decision-making

Medtech innovation briefing Published February 2017

Boston Keratoprosthesis Type I for corneal blindness (MIB91)

Advice on the use of Boston Keratoprosthesis Type I for treating corneal blindness to aid local decision-making

Medtech innovation briefing Published January 2017

Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis (MIB93)

Advice on the use of the Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis to aid local decision-making

Medtech innovation briefing Published January 2017

CentriMag for heart failure (MIB92)

Advice on the use of CentriMag for heart failure to aid local decision-making

Medtech innovation briefing Published January 2017

Refractory extrapulmonary sarcoidosis: infliximab (ES4)

Summary of the evidence on infliximab for treating refractory extrapulmonary sarcoidosis to inform local NHS planning and decision-making

Evidence summary Published January 2017

Smartinhaler for asthma (MIB90)

Advice on the use of Smartinhaler for monitoring the activation of asthma inhalers to aid local decision-making

Medtech innovation briefing Published January 2017

Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate (ES3)

Summary of the evidence on conjugated oestrogens and bazedoxifene acetate for oestrogen deficiency symptoms to inform local NHS planning and decision-making

Evidence summary Published December 2016

Organ donation for transplantation

Everything NICE has said on improving donor identification and consent rates for deceased organ donation for transplantation in an interactive flowchart

NICE Pathway Published February 2012 Last updated December 2016

Pulmonary sarcoidosis: infliximab (ES2)

Summary of the evidence on infliximab for treating pulmonary sarcoidosis to inform local NHS planning and decision-making

Evidence summary Published December 2016

CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes (MIB48)

Advice on the use of the CORTRAK 2 Enteral Access System (EAS) for the placement of nasoenteral feeding tube to aid local decision-making

Medtech innovation briefing Published January 2016 Last updated December 2016

Neonatal jaundice

Everything NICE has said on diagnosing and treating jaundice in newborn babies under 28 days in an interactive flowchart

NICE Pathway Published May 2011 Last updated December 2016

Mental wellbeing and independence in older people

Everything NICE has said on promoting mental wellbeing and independence in older people over 65 in an interactive flowchart

NICE Pathway Published November 2012 Last updated December 2016

Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)

Advice on the use of Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions to aid local decision-making

Medtech innovation briefing Published November 2016

Sternal Talon for sternal closure in cardiothoracic surgery (MIB88)

Advice on the use of Sternal Talon for closing the sternum in cardiothoracic surgery to aid local decision-making

Medtech innovation briefing Published November 2016

CytoSorb therapy for sepsis (MIB87)

Advice on the use of CytoSorb therapy for treating sepsis to aid local decision-making

Medtech innovation briefing Published November 2016

OCS Heart system for heart transplant (MIB86)

Advice on the use of OCS Heart system for monitoring and preserving donor hearts to aid local decision-making

Medtech innovation briefing Published November 2016

Lifestyle weight management services for overweight or obese adults

Everything NICE has said on lifestyle weight management services for overweight or obese adults in an interactive flowchart

NICE Pathway Published May 2014 Last updated November 2016

Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab (ES1)

Summary of the evidence on rituximab for minimal change disease and focal segmental glomerulosclerosis to inform local NHS planning and decision-making

Evidence summary Published November 2016

Needle-free arterial non-injectable connector (MIB85)

Advice on the use of needle-free arterial non-injectable connector through which blood samples can be collected to aid local decision-making

Medtech innovation briefing Published October 2016

Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

Medtech innovation briefing Published October 2016

Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)

Advice on the use of Woundchek Protease Status for assessing elevated protease status in chronic wounds to aid local decision-making

Medtech innovation briefing Published October 2016

UrgoStart for chronic wounds (MIB82)

This advice has been updated and replaced by NICE medical technologies guidance 42.

Medtech innovation briefing Published October 2016

Pre-exposure prophylaxis of HIV in adults at high risk: Truvada (emtricitabine/tenofovir disoproxil) (ESNM78)

Summary of the evidence on Truvada (emtricitabine/tenofovir disoproxil) for pre-exposure prophylaxis (PrEP) of HIV in adults at high risk

Evidence summary Published October 2016

Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)

Advice on the use of the Alere Afinion CRP for C-reactive protein testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

FLEXISEQ for osteoarthritis (MIB80)

Advice on the use of FLEXISEQ for treating the symptoms of osteoarthritis to aid local decision-making

Medtech innovation briefing Published September 2016

VitalPAC for assessing vital signs of patients in hospital (MIB79)

Advice on the use of VitalPAC for assessing vital signs of patients in hospital to aid local decision-making

Medtech innovation briefing Published September 2016

QuikRead go for C-reactive protein testing in primary care (MIB78)

Advice on the use of QuickRead go for C-reactive protein (CRP) testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

OSNA for colon cancer staging (MIB77)

Advice on the use of OSNA in vitro diagnostic molecular assay system for staging colon cancer to aid local decision-making

Medtech innovation briefing Published August 2016

Axxent electronic brachytherapy system for early stage breast cancer (MIB76)

Advice on the use of the Axxent electronic brachytherapy system for treating early stage breast cancer to aid local decision-making

Medtech innovation briefing Published August 2016

Ultroid 2.0 for internal haemorrhoids (MIB75)

This medtech innovation briefing is temporarily unavailable, please contact mibs@nice.org.uk for further information.

Medtech innovation briefing Published July 2016

Stretta System for gastro-oesophageal reflux disease (MIB74)

Advice on the use of Stretta System for gastro-oesophageal reflux disease (GORD)

Medtech innovation briefing Published July 2016

QTUG for assessing falls risk and frailty (MIB73)

Advice on the use of the Quantitative Timed Up and Go (QTUG) to assess mobility, falls risk and frailty during the standard Timed Up and Go (TUG) test to aid…

Medtech innovation briefing Published July 2016

Lutonix drug-coated balloon for peripheral arterial disease (MIB72)

NICE withdrew this medtech innovation briefing in October 2019 after the MHRA withdrew support for this type of technology being used in intermittent claudication for arterial disease.

Medtech innovation briefing Published July 2016

Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)

Advice on the use of the Alair bronchial thermoplasty system for treating adults with severe, difficult to control asthma to aid local decision-making

Medtech innovation briefing Published July 2016